Tabula Rasa HealthCare Prices IPO at $13.00-$15.00 Per Share (TRHC)
In the last year, Tabula Rasa HealthCare generated $80.3 million in revenue and had a net loss of $10.7 million. Tabula Rasa HealthCare has a market cap of $217.1 million.
Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.
Tabula Rasa HealthCare provided the following description of their company for its IPO: “We are a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. We deliver our solutions through a comprehensive suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. We also provide risk adjustment services, which help our clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. “.
Tabula Rasa HealthCare was founded in 2014 and has 198 employees. The company is located at 110 Marter Avenue, Suite 309, Moorestown, NJ 08057, US and can be reached via phone at (866) 648 – 2767 or on the web at http://www.tabularasahealthcare.com.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.